SHORTDAX X9 PR EUR/ DE000A13PH09
ZK2L30.05.2024 12:49:50 | Diff. +1,68 | Eröffnung | Tageshoch | Tagestief | Schluss Vortag |
---|---|---|---|---|---|
158,01XXP | +1,07% | 159,05 | 164,45 | 156,46 | 156,33 |
GlobeNewswire
13:00
Elevar Therapeutics Reports Landmark Median Overall Survival of 23.8 Months in First-Line Treatment ...
GlobeNewswire
13:00
Troilus Discovers New At-Surface Gold Zone ‘West Rim’ With Intercept of 1.37 g/t AuEq Over 11m Withi...
GlobeNewswire
13:00
BiomX to Present Phase 1b/2a Clinical Trial Data for BX004 at the 47th European Cystic Fibrosis Conf...
GlobeNewswire
13:00
Beamr Cloud upgrade for enterprises: customizable video service with enhanced security and privacy
GlobeNewswire
13:00
Fortrea Introduces Comprehensive Solution to Improve Diversity and Inclusion in Clinical Research
GlobeNewswire
13:00
SERB Pharmaceuticals appoints Vanessa Wolfeler as CEO to drive next stage of the company’s growth
GlobeNewswire
13:00
Tiziana Life Sciences Scientific Board Chairman to Receive Prestigious Award for Multiple Sclerosis ...
GlobeNewswire
13:00
17 Education & Technology Group Inc. to Report First Quarter 2024 Unaudited Financial Results on Jun...
GlobeNewswire
13:00
Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and P...
GlobeNewswire
13:00
Celcuity Inc. Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line Trea...
GlobeNewswire
13:00
Rivalry Reports First Quarter 2024 Results, Expands Into Crypto Segment Through Rivalry Token
GlobeNewswire
13:00
Virtu Financial, Inc. Announces Investor Meetings for Potential Opportunistic Offering of Senior Sec...
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite